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African green monkeys (AGMs) are divided into four species (Cercopithecus aethiops, C. pygerythrus, C. sabaeus, C.
tantalus), each harboring a species-specific simian immunodeficiency virus (SIVagm). Little is known about the host and/or
viral factors that are responsible for the apathogenicity of SIVagm infections in their natural hosts. In order to analyze the
specific selective pressures exerted by the host on the virus in vivo, we compared the genetic evolution of SIVagm.tan in
its natural host (C. tantalus) and in a foreign host species (Erythrocebus patas), in which we could obtain a reproducible
and persistent infection by SIVagm.tan. As in AGMs, patas monkeys do not develop any disease following SIVagm infection.
Our longitudinal study in env (V3-C3-V4-C4-V5) of SIVagm.tan from three AGMs and three patas monkeys revealed a high
ratio of synonymous to nonsynonymous mutation frequencies (1.5–6.2). These data indicate that the selective pressures
for stability exerted by AGMs and patas monkeys on SIVagm override positive selection for change reported in pathogenic
HIV-1 infections. The rapid accumulation of mutations observed in AGMs and patas monkeys (0.4–7.2 1 1002 nucleotide
substitutions per site per year) suggests a continuous replication of SIVagm viruses in vivo. We thus propose that nonpatho-
genic SIVagm infections are the result of a long-term selection of SIVagm variants whose dissemination can be controlled
in the host, rather than being explained by a low ability of the virus to replicate in vivo. q 1996 Academic Press, Inc.
INTRODUCTION SIVagm.ver, SIVagm.gri, SIVagm.sab, and SIVagm.tan (Al-
lan et al., 1990, 1991; Fomsgaard et al., 1991; Hirsch et
African monkeys can be naturally infected by simian al., 1993; Jin et al., 1994a; Mu¨ller et al., 1993). These
immunodeficiency viruses (SIV). These viruses were viruses seem to have coevolved with their natural host
named according to the species from which they were species and may represent the oldest primate lentivi-
isolated. The lentiviruses SIVsm, SIVmnd, SIVcpz, SIVsyk, ruses (Allan et al., 1991; Johnson et al., 1990; Mu¨ller et
SIVtal, and SIVagm have thus been respectively obtained al., 1993). In addition, SIVs genetically related to SIVagm
from sooty mangabeys (Cercocebus atys), mandrills viruses were isolated from three other African monkey
(Papio sphinx), chimpanzees (Pan troglodytes), sykes species, the white-crowned mangabey (Cercocebus tor-
monkeys (Cercopithecus mitis), talapoin monkeys (Miopi- quatus lunulatus), the yellow baboon (Papio hamadryas
thecus talapoin), and African green monkeys (Cercopi- cynocephalus) (Jin et al., 1994b; Tomonaga et al., 1993),
thecus aethiops) (Bosch et al., 1994; Emau et al., 1991; and the patas monkey (Erythrocebus patas) (Bibollet-
Fukasawa et al., 1988; Fultz et al., 1986; Lowenstine et Ruche et al., 1996). The SIV infections in the yellow ba-
al., 1986; Peeters et al., 1989; Tsujimoto et al., 1988). boon and the patas monkey probably result from simian-
The African green monkey (AGM) superspecies is further to-simian cross-species transmissions in natura of
subdivided into four species, the vervet (Cercopithecus SIVagm.ver and SIVagm.sab, respectively. In contrast,
pygerythrus), grivet (Cercopithecus aethiops), sabaeus New World and Asian monkeys are not infected by SIV
(Cercopithecus sabaeus), and tantalus monkey (Cercopi- in the wild (Hendry et al., 1986; Lowenstine et al., 1986;
thecus tantalus) (Lernould, 1988). Each of those harbors Ohta et al., 1988). Phylogenetic studies indicated that
a species-specific SIVagm subtype, respectively named SIVmac resulted from SIVsm cross-species transmission
between sooty mangabeys and macaques in captivity
approximately 30 years ago (Hirsch et al., 1989).
1 Present address: Centre International de Recherches Me´dicales, Persistent SIV infections in naturally infected African
Franceville, Gabon.
nonhuman primates are not associated with clinical2 To whom reprint requests should be addressed at Unite´ de Biologie
signs of immunodeficiency, in contrast to HIV or SIV in-des Re´trovirus, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris, Cedex
15, France. Fax: 33 1 45 68 89 57. fections in humans or macaques, respectively. The rea-
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sons for the lack of pathogenicity of SIVs in their natural about the date of his exposure to the virus in the wild is
available.hosts in Africa are far from being fully understood. It
was shown that experimental passages of SIVsm or
SIVagm.ver into an Asian nonhuman primate species, Experimental inoculation of AGMs and patas
the pig-tailed macaque (Macacca nemestrina), can result monkeys with SIVagm.tan
in an immunodeficiency syndrome similar to human AIDS
Two AGMs and four patas monkeys were inoculated(Fultz et al., 1989; Hirsch et al., 1995). These viruses
intravenously with SIVagm.tanB14 infectious material ob-are therefore not nonpathogenic per se, but can induce
tained from the naturally infected AGMB14, from one ex-disease in a specific foreign species. Recent studies
perimentally infected AGM, or from one experimentallystrongly indicate that pathogenicity correlates with the
infected patas monkey (Table 1). The experimental infec-extent of viral load in vivo, both in humans (Cao et al.,
tions were done as follows. Two milliliters of plasma and1995; Piatak et al., 1993) and in monkeys (Hirsch et al.,
106 PBMC from the naturally infected AGMB14, collected1995; Marthas et al., 1989). Viral burden depends both
5 months after its capture, were inoculated into a patason the ability of the virus to multiply in the host and on
monkey (PAT5). Nine months later, 5 ml of blood andthe capacity of the host to control the viral infection.
spleen cells from PAT5 were injected into a second patasAccording to the error-prone replication mechanism of
monkey (PAT40). A third patas monkey (PAT63) was inoc-retroviruses, the accumulation of mutations in the viral
ulated with 106 PBMC which were previously infected ingenome is related to the number of replication cycles
vitro with a SIVagm.tanB14 supernatant. This supernatant(Temin, 1993). A low level of viral replication in the natural
resulted from a short-term in vitro culture of AGMB14host should therefore be characterized by a slow accu-
PBMCs obtained 1 year after its capture. A fourth patasmulation of mutations.
monkey (PAT87) and one AGM (AGMB86) each receivedOnly few comparative data are available on the genetic
2 ml of plasma collected from the AGMB14 three yearsevolution of nonpathogenic primate lentiviruses in their
after its capture. Two months later, 2 ml of plasma andnatural hosts and after experimental cross-species trans-
106 PBMC from AGMB86 were inoculated into a secondmissions into a foreign monkey species (Courgnaud et
AGM (AGMB87). The serological status of the animalsal., 1992; Fomsgaard et al., 1993). We report here such
was regularly followed by commercialized HIV-2 Westerncomparative data for the SIVagm.tan in its natural host,
blots (New Lav Blot II, Diagnostic Pasteur), accordingi.e., the AGM from the tantalus species, and in a distinct
to the cross-reactivities between SIVagm.tan and HIV-2simian species from Africa, the patas monkey. The patas
antigens (Mu¨ller et al., 1993).monkey apparently does not carry any patas-specific SIV
in the wild (Bibollet-Ruche et al., 1996; Herve´ et al., 1992;
Virus isolationsLowenstine et al., 1986), but we show that it can be
reproducibly and persistently infected by SIVagm. Since Blood samples were regularly collected from each ani-
the patas monkey is not the natural environment of mal. The PBMCs were isolated on Ficoll–Hypaque gradi-
SIVagm, we speculate that the selective pressures ex- ents and stimulated for 3 days with staphylococcal en-
erted on the virus in this foreign host might be different terotoxin A (SEA) at a concentration of 0.5 mg/ml. The
from that in AGMs, to which it is adapted. In order to test cells were then maintained in the presence of Interleukin-
this hypothesis, we focused our comparative analysis on 2 and the supernatants monitored twice weekly for re-
one env region, which seems to be submitted to a high verse transcriptase activity (Barre´-Sinoussi et al., 1983).
positive selection for change during pathogenic primate The isolation of SIVagm.tanB14 from the naturally in-
lentivirus infections (Balfe et al., 1990; Burns and Desro- fected animal was previously reported (Mu¨ller et al.,
siers, 1991; Myers et al., 1994). 1993).
MATERIALS AND METHODS DNA extraction and PCR amplification
Animals Since the number of PBMCs carrying proviral DNA
seemed to be low (unpublished observations), the cellsAGMs (C. tantalus) and patas monkeys (E. patas) were
were cultured in vitro for 6 days to increase the numberwild caught in the Central African Republic (C.A.R.) and
of SIV-infected cells before DNA extraction. For the longi-hold in animal facilities at the Pasteur Institute in Bangui.
tudinal study of SIVagm in the naturally infected AGMB14,One of the AGMs (AGMB14) was naturally infected by
we analyzed the proviral DNA obtained 1, 3, and 4 yearsSIVagm.tanB14 as previously described (Mu¨ller et al.,
after the capture of the animal. For all experimentally1993). All the other animals were SIV-seronegative as
infected animals, at least one time point between sero-assessed by Western blot analysis (New Lav Blot I, New
conversion and 6 months p.i. was analyzed. The laterLav Blot II, Diagnostic Pasteur) with 0.2 ml of serum. The
time points studied were 112 years p.i. for AGMB86,naturally infected AGM was approximately 3 years old
when he was captured and obviously no information AGMB87, and PAT63 and 3–312 years p.i. for AGMB87
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TABLE 1
Follow-up of SIVagm-Infected Tantalus and Patas Monkeys
Source of SIV Follow-up Persistent Proviral
Animal inoculuma (years p.i.) Seroconversion infectionb DNAc
AGMB14 Natural infection 4 / / /
AGMB86 AGMB14(B) 1,5 / / /
PAT5 AGMB14 1,5 / / nd
PAT63 AGMB14(A) 1,5 / / /
PAT87 AGMB14(B) 1,5 / / /
AGMB87 AGMB86(A) 3,5 / / /
PAT40 PAT5 3,5 / / /
a The inocula specified by an (A) or (B) designate biological material from which corresponding viral isolates had been obtained for the genetic
study.
b The presence of a persistent infection was assessed regularly by virus isolation from monkey PBMCs.
c Proviral DNA was repeatedly detected in monkey PBMCs by nested PCR during the follow-up. nd, not determined.
point agarose gels and purified with centrifuge filtersand PAT40. The first, second, and third samples of each
(Spin-X, Costar). Fragments of the expected size, but alsoanimal were called respectively, A, B, and C. The patas
fragments of a smaller size, were purified because ofPAT5 died with symptoms unrelated to AIDS 9 months
possible SalI restriction sites in not yet identified viralafter SIVagm inoculation and no PBMCs from this animal
variants. The fragments were then ligated to SalI-di-were available for the longitudinal study. The PBMCs
gested, dephosphorylated pUC18 vectors. After transfor-were lysed and genomic DNA was extracted in a sepa-
mation of competent JM109 Escherichia coli cells, plas-rate room using standard techniques.
mids were purified on anion-exchange columns (QiagenOne microgram of DNA was used for nested PCRs
Plasmid Purification, Qiagen).with first NS3s (TGTAGGAGACCAGGAAACAAGACA)/
NS3as (AAGCCTAAGAACCCTAGCACAAA) as outer
primer pair and S1 (CAACAGTCGACCCAGTAACCATC- Heteroduplex mobility assays (HMA)
ATGGC)/S4 (TCTGTTGGAGTCGACCCTATTGGT) as in-
HMA (Delwart et al., 1993) was performed on two inoc-ner primer pair. The outer primers correspond to HIV2/
ula that were available and on two sequential viral iso-SIVmac/SIVagm consensus sequences and the inner
lates from each of the respective recipient animalsprimers to SIVagm.tan consensus sequences. The inner
(AGM87 and PAT63). Five independent PCR reactionsprimers span the nucleotides from positions 796 to 1436
were first performed for each viral sample to be analyzedwithin the env gene of SIVagm.tanB14. The underlined
according to the PCR conditions described above. Then,nucleotides indicate terminal SalI restriction sites which
250 ng of each nested PCR product was denatured inwere used for subsequent cloning of PCR amplified frag-
an annealing buffer (0.1 M NaCl, 10 mM Tris–HCl, pHments. Cycling parameters of the PCR were as follows:
7.8, 2 mM EDTA) at 947 for 2 min. In addition, 125 ng of35 cycles at 947 for 1 min (3 min in the first cycle), 557
nested PCR products corresponding to two different viralfor 1 min, and 727 for 1 min (5 min for the last cycle).
samples was mixed before denaturation. Hetero-PCRs were performed under standard buffer conditions
duplexes were obtained by reannealing PCR-amplified(Mu¨ller et al., 1993). One to 5 ml from the first-round
sequences through cooling on wet ice. Heteroduplex mo-reaction was used for the second-round PCRs. Products
bility was analyzed on a neutral, 6% polyacrylamide gelfrom repeated PCR reactions with a same DNA sample
(250 V for 3 hr). Signals were visualized by staining withwere pooled before cloning. In addition, products from
ethidium bromide.three repeated PCRs on PBMCs of three animals
(AGMB14, AGMB87, and PAT63) were not pooled, but
Sequence determination and analysiswere independently cloned and sequenced in order to
evaluate the eventual variations related to PCRs.
Double-stranded plasmid DNA was denatured with al-
kaline and sequenced by the dideoxynucleotide chainCloning of PCR products
termination method (Sequenase 2.0 Sequencing kit,
U.S.B.). Both sense and antisense sequences were deter-PCR products were extracted with chloroform, ethanol
precipitated, and then digested with SalI. SalI restriction mined using forward and reverse pUC-sequencing prim-
ers as well as the inner primers AE5s (AGACAATGG-sites were chosen because they are absent in all known
SIVagm.tan sequences of the selected env region. The GGAGACCCAG) and MMas (TTCAGATAATTTAGAAAC-
CAATC).DNA fragments were then separated on low-melting-
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TABLE 2 substitutions were calculated in a classical pairwise
comparison (Nei and Gojobori, 1986) between relatedSIVagm Intraisolate Variability
sequences defined by the minimal trees. We calculated
Mean divergence (%)b first the number of sites where synonymous and nonsyn-
Viral onymous substitutions can occur (Nei and Gojobori,
isolatea time p.i. (years) Nucleotides Amino acids 1986). The ratio of synonymous (and nonsynonymous)
mutations per site was then determined by dividing theAGMB14(A) 1 1.1 4.8
observed number of synonymous (and nonsynonymous)AGMB14(B) 3 2.5 4.0
AGMB14(C) 4 2.5 4.6 mutations (Ms and Ma) by the calculated number of syn-
AGMB86(A) 0.5 (8 weeks) 2.3 1.7 onymous (and nonsynonymous) sites (Ss and Sa). The
AGMB86(B) 1.5 0.2 0.4 Ks/Ka ratio for sequences from a same isolate was calcu-
AGMB87(A) 0.5 2.0 3.9
lated according to the formula Ks/Ka ((Ms/(Ss)/((Ma/AGMB87(B) 1.5 1.6 2.8
(Sa). The methods used in the literature to calculate Ks/AGMB87(C) 3 1.9 2.3
PAT40(A) 0.5 (6 weeks) 1.1 1.9 Ka ratios are slightly heterogenous. In order to better
PAT40(B) 3.5 1.2 1.9 compare our data to Ks/Ka values of the literature, we
PAT63(A) 0.5 0.5 0.9 analyzed published HIV-1 env sequences from a hemo-
PAT63(B) 1.5 1.2 1.1
philiac patient sequentially obtained over a 5-year periodPAT87(A) 0.5 (4 weeks) 1.1 1.3
(Simmonds et al., 1991) and from 9 symptomatic patientsPAT87(B) 0.5 (15 weeks) 0.5 0.7
of Central Africa infected by HIV-1 subtype A (Murphey
a (A), (B), and (C) refer respectively to the first, second, or third isolate. et al., 1993). HIV-1 subtype A env sequences from 14
b Mean intraisolate divergences were determined between the vari- early seroconvertors were also analyzed (manuscript in
ants identified in sequential isolates from each animal. Only the pairs of
preparation). For these three groups of HIV-1 sequences,sequences which are related in the minimal trees that were previously
the Ks/Ka ratios we obtained ranged from 0.8 to 2.1 (dataestablished for each individual isolate are considered.
not shown) and were therefore comparable to those es-
tablished by many other groups for HIV-1 (Balfe et al.,
1990; Lukashov et al., 1995; Wolinsky et al., 1992).Sequences were aligned with CLUSTAL (Higgins et al.,
1992) and corrected manually. Phylogenetic trees were
performed by using the PHYLIP package (Felsenstein, Nucleotide sequence Accession numbers
1990).
The nucleotide sequences described in this paperThe minimal trees were constructed with a program
have been submitted to the GenBank database underusing Prim’s algorithm (Prim, 1957). For this, spanning
Accession numbers U28506–U28640.trees are first constructed in which pairs of sequences
are directly connected to each other and not through a
RESULTStheoretical ancestor as in classical phylogenetic trees.
These trees are then evaluated by the sum of nucleotide Cross-species transmission of SIVagm.tan can occur
substitutions between pairs of connected sequences. into patas monkeys
The minimal tree corresponds to the spanning tree show-
ing the lowest sum of substitutions. Only the distances Four monkeys, belonging either to the natural host
species of SIVagm.tan or to a foreign species, the patasbetween the connected sequences in the minimal tree
are used for the determination of the genetic variability. monkey, were experimentally inoculated with blood de-
rivatives from a naturally SIVagm-infected monkey (TableThis method avoids a pairwise comparison of all se-
quences present in the isolates and which are not neces- 1). For one AGM and one patas monkey, the virus was
then passaged to a second animal of the same species.sarily phylogenetically related. This method also ex-
cludes the possibility of counting the same mutation We used infectious material containing whole viral popu-
lations rather than molecular clones for the inoculationsmore than once. It therefore avoids an overestimation of
the genetic variability. It may even in some cases lead because they might be more representative of natural
infections in vivo. After 2 months, both AGMs and patasto an underestimation of the genetic distances since
identical mutations which emerged independently are monkeys developed an antibody response as indicated
by reactivities with HIV-2 antigens on commercial West-not taken into consideration.
The nonparametric U test of Mann–Whitney was used ern blots (data not shown). These antibodies persisted
in the animals throughout their follow-up. All the animalsto evaluate the significance of the differences in the vari-
ability between SIVagm isolates from AGM and patas were presenting antibodies against the surface glycopro-
tein (SU), but reactivities with the transmembrane glyco-monkeys. The values were obtained by considering all
the distances that give rise to the mean intraisolate diver- protein were weak. As already reported for SIVagm-in-
fected AGMs (Daniel et al., 1988; Mu¨ller et al., 1993;gences shown in Table 2.
The frequencies of synonymous and nonsynonymous Ohta et al., 1988), the four infected patas monkeys also
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showed only a low immune response to the p26 major tinct variants originally present in PBMC-extracted DNA.
In addition, the amplified sequences which were ob-core protein.
SIVs were repeatedly isolated from the PBMCs of all tained from independent PCR reactions on the same
PBMC DNA sample always showed an identical HMAseroconverted AGM and patas monkeys (Table 1). Provi-
ral DNA was persistently detected by PCR in the sequen- pattern and also did not phylogenetically cluster together
according to the PCR reaction (data not shown). Thus,tially obtained PBMCs from all tested AGM and patas
monkeys (AGMB14, AGMB86, AGMB87, PAT40, PAT63, although the number of clones analyzed per sample is
too limited to identify every variant present in PBMCs, theand PAT87) after seroconversion (Table 1). However, a
nested PCR was always required to obtain detectable clones should be representative of the overall variability.
The viral populations therefore appear heterogeneousamplification signals of proviral DNA by ethidium bro-
mide staining (data not shown). in naturally and experimentally infected AGMs as well
as in SIVagm-infected patas. However, the cysteines andThe animals were followed until 112 to 4 years p.i. (Table
the potential N-glycosylation sites are conserved among1). During this period, we did not observe any significant
the variants of each viral population from both AGM anddecline of CD4 cells in AGMs nor in patas monkeys (data
patas monkeys (Fig. 1). There is no evidence of specificnot shown). None of the SIVagm-infected AGM and patas
amino acid mutations emerging in patas monkeys com-monkeys showed clinical signs of immunodeficiency.
pared to AGMs. The sequence motifs in the V3 to V5
region, which were reported as specific for SIVagm fromSequential SIVagm isolates from both AGM and patas
AGMs of the tantalus species (Jin et al., 1994a; Mu¨ller etmonkeys contain a high proportion of distinct variants
al., 1993), are conserved even when the virus is transmit-
ted into patas monkeys.To compare the genetic evolution of SIVagm in AGMs
and patas monkeys, viral variants present in simian Twelve of the 79 analyzed AGM clones (15%) were
presenting a high level of G to A substitutions. This phe-PBMCs at different time points after infection were ana-
lyzed. In the case of the naturally infected animal nomenon was already described for other primate lentivi-
ruses (Daniel et al., 1988; Johnson and Hirsch, 1992; Ohta(AGMB14), the analysis was performed on three sequen-
tial samples obtained 1, 3, and 4 years after its capture. et al., 1988). According to the genetic code, the G to A
substitutions induce the appearance of charged aminoFor each experimentally inoculated AGM or patas mon-
key, we analyzed at least two different time points lying acids like asparagine (N), glutamic acid (E), and lysine
(K) and also modify tryptophan coding codons (TGG) intobetween 1.5–6 months p.i. and/or 18–39 months p.i. The
env region spanning the conserved and variable V3, C3, stop codons (TAA) (Fig. 1). Among the 16 env clones from
AGMs with stop codons, 75% of them indeed presentedV4, C4, and V5 domains was chosen for the comparative
study. The localization of these domains corresponded a high level of G to A substitution. Stop codons were
also found in 4 of 56 patas clones (0.7%), but G to Ato that of HIV-1, except that V3 is localized 3* of the
HIV-1 V3 loop (Mu¨ller et al., 1993). In total, 136 clones hypermutated sequences were not identified in the patas
isolates. However, we may not have analyzed enoughcontaining the selected 540-bp env fragments were se-
quenced. Only one clone, corresponding to one AGMB87 clones to be able to exclude the existence of this phe-
nomenon in patas monkeys.variant, was shorter because of an internal SalI restric-
tion site. Its sequence was very similar to the other
AGMB87 variants and was not included in the genetic SIVagm variants transmitted to two AGMs cluster
analysis. irrespective of the recipient animal, in opposition to
Among the sequential SIVagm isolates from the donor those transmitted to three patas monkeys
monkey AGMB14, no dominant variant was identified.
The alignment of the amino acid sequences (Fig. 1) was The nucleotide sequence alignment was used to con-
struct a phylogenetic tree shown in Fig. 2. SIVagm envtherefore performed with regard to a consensus se-
quence of all AGMB14 clones. Eight isolates obtained variants identified over time in the same AGM monkey
were found in different clusters. The variants from thefrom two AGMs (AGMB14, AGMB87) and two patas
(PAT40, PAT87) essentially contained unique env nucleo- naturally infected animal and the two experimentally in-
fected AGMs are very close to each other and do nottide sequences. The remaining five additional isolates
obtained from two AGMs (AGMB14, AGMB86) and one cluster together according to the animal. The position of
the variants within a same cluster, but not the positionpatas monkey (PAT63) were containing identical clones,
but a high proportion of unique env sequences was also of the clusters themselves, could change according to
the method used to construct the phylogenetic tree (dataidentified. The variants differed from each other by 1 to
58 nucleotide substitutions. Since the majority of viruses not shown). In contrast to the AGM viruses, the viral
populations identified in the three patas monkeys areshowed a distinct env sequence, it is unlikely that we
analyzed several clones resulting from PCR amplification clearly separated into three single groups, each corre-
sponding to a distinct recipient animal. We never identi-of an identical proviral copy, but we rather amplified dis-
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FIG. 1. Alignment of deduced amino acid sequences (positions 328–508 in SIVagm-TYO-1 (Fukasawa et al., 1988) from SIVagm variants present
in sequentially obtained PBMC samples designated A, B, and C. The number of nucleotide sequences that were found identical in the same isolate
is indicated. Each of such identical sequences is presented once on the alignment. V3, V4, and V5 refer to the hypervariable regions previously
determined for SIVagm (Mu¨ller et al., 1993). The localization of V3 corresponds thus to that of V3 of SIVmac (Burns and Desrosiers, 1991), but not
to V3 of HIV-1 (Modrow et al., 1987). Asterisks mark conserved cysteines and circles indicate conserved potential N-glycosylation sites. Dots
represent amino acid identity and dashes designate gaps. Stars indicate stop codons.
fied patas variants from two distinct monkeys in the same SIVagm from AGMs. For instance, all the PAT63 variants
except one (PAT63B2) are close to those from isolatecluster whatever method we used to construct the phylo-
genetic tree. Patas variants were sometimes close to A of AGMB14. This is not surprising since this isolate
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viral populations in the inocula may thus have been dif-
ferent. They also may have contained fewer variants than
those used to inoculate the AGMs. However, one AGM
(AGMB86) and one patas monkey (PAT87) received ex-
actly the same infectious plasma sample, but only the
patas variants were found to cluster according to the
host animal in this experiment.
SIVagm intraisolate variability is higher in AGMs than
in patas monkeys
The mean nucleotide divergences between variants of
a same isolate ranged from 0.2 to 2.5% in AGMs and
from 0.5 to 1.2% in patas monkeys (Table 2). No correla-
tion exists between the number of clones analyzed per
sample and the extent of variability. The maximal dis-
tances were always found among clones of AGM iso-
lates. For example, two variants of the first AGMB86 iso-
late diverged by 58 nucleotide substitutions (10.9%) due
to G to A hypermutation in one of those variants. Since
this distance to the hypermutated sequence is consid-
ered only once in the minimal trees used for the calcula-
tion of the variability, the hypermutated sequences do
not alter significantly the mean divergences. The mean
intraisolate amino acid variability varied from 0.4 to 4.8%
for AGMs and from 0.7 to 1.9% for patas monkeys. The
culture of monkey PBMCs during 6 days in vitro before
DNA extraction should be considered as a possible
source of mutations that may not be representative of
the initial material. However, according to a study on
the SIVagm.ver-derived reverse transcriptase, the rate of
errors introduced during the replication in vitro is about
5.4 1 1005 base substitutions per nucleotide and per
replication cycle (Manns et al., 1991). A replication cycle
in vitro occurs approximately every 24 hr (Kim et al.,
1989). According to this information, no more than 0.18
substitutions may have been introduced into our 540-bp
env fragment during the short-term culture in vitro. In-
deed, such an estimate corresponds to the experimen-
tally determined molecular data previously reported
(Burns and Desrosiers, 1991; Tolle et al., 1994). The varia-
tion rate we observed is also significantly higher than
the frequency of errors due to the Taq polymerase that
was reported to correspond to 0.4 substitutions/540 bp
(0.07%) for 60 amplification cycles of PCR (Ennis et al.,
1990; Johnson et al., 1991). We can thus consider our
values, which indicate much more divergences thanFIG. 1—Continued
those due to experimental conditions, as representative
of the viral populations circulating in the infected ani-
mals.corresponds to the PAT63 inoculum. Similarly, one
SIVagm variant from isolate B of AGMB14, which corre- Based on these values, the intraisolate variability was
significantly lower in patas monkeys than in AGMs. Thesponds to the PAT87 inoculum, is mixed within the group
of the PAT87 variants. Unfortunately, the PAT40 variants differences were significant even when the G to A hyper-
mutated sequences were not considered (P  0.0216).could not be compared to the inoculum, which was not
available for sequencing. The three patas monkeys were It is interesting to notice that in four of five animals, the
heterogeneity early after infection (0.5 year p.i.) is notnot inoculated with the same infectious material and the
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FIG. 2. Phylogenetic tree depicting evolutionary relationships between env nucleotide sequences (positions 6781–7293 in SIVagm-TYO-1 (Fuka-
sawa et al., 1988) of SIVagm variants that are emerging in AGMs and patas monkeys. The identical sequences of a same isolate were excluded.
A, B, and C refer respectively to the first, second, or third SIV PBMC sample from each individual animal. The tree was derived by maximum
parsimony (Swofford, 1984). Trees based on a distance matrix and generated with the neighbor-joining algorithm (Saitou and Nei, 1987) or the
Fitch-Margoliash method (Fitch and Margoliash, 1967) resulted in similar branching patterns.
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TABLE 3
Fixation Rate of Nucleotide Substitutions per Site and per Year in SIVagm env Sequences in Vivoa
AGMB14 AGMB86 AGMB87 PAT40 PAT63 PAT87
2.6 1 1002 3.2 1 1002 1.8 1 1002 0.4 1 1002 1.0 1 1002 7.2 1 1002
a Those variants in isolates A (or B) were selected that show the minimal distance to a variant in isolates B (or C) from the same monkey. The
nucleotide fixation rate was determined by calculating the mean value of nucleotide substitutions between these pairs of variants respective to the
time interval between the sequential isolates. The G to A hypermutated sequences were not considered.
lower than later after infection (Table 2), as if the degree lane 3), indicating the presence of some variants that are
of genetic polymorphism does not increase over time not detected in the inoculum and the previous sequential
during the infection, neither in AGM nor in patas mon- isolate. The mixing of the PCR products from the inocu-
keys. lum and the two AGMB87 isolates with each other always
resulted in a unique profile (Fig. 3A, lanes 4, 5, and 6),
The fixation rate of nucleotide substitutions in confirming that the viral populations are not identical.
SIVagm is high in AGM and patas monkeys Distinct HMA patterns were also observed for the two
PAT63 sequential isolates, but to a lower extent. TheIn order to compare mutation rates of SIVagm in AGMs
PAT63 B isolate indeed shows a diffused DNA band thatand patas monkeys, we estimated the number of muta-
migrated more slowly than the homoduplexes (Fig. 3B,tions fixed in the V3 to V5 env region after a specific time
lane 3) and that could be detected neither in the inoculuminterval in each animal. In AGMs, the mean fixation rate
(Fig. 3B, lane 1) nor in the PAT63 A isolate (Fig. 3B, laneof nucleotide substitutions ranged from 1.8 1 1002 to 3.2
2). After mixing the PCR products of the inoculum and the1 1002 per site and per year (Table 3). Similar values
PAT63 A isolate, no heteroduplexes could be detected(0.4 1 1002 to 7.2 1 1002 nucleotide substitutions per
indicating that the viral populations in these two samplessite and per year) were obtained for patas monkeys,
are similar (Fig. 3B, lane 4). The mixing of the PCR prod-although a higher level of interindividual variation was
ucts from the PAT63 B isolate with the PAT63 inoculumobserved.
(Fig. 3B, lane 5) or the PAT63 A isolate (Fig. 3B, lane 6),It must be remembered that our sequence analysis
however, revealed again the diffused migrating hetero-does not allow us to identify every genotype contained
duplexes, showing that the second PAT63 isolate is morein one PBMC sample. Some variants identified in the
animals may already have been present in the inoculum
or in previous isolates without being detected. Differ-
ences between variants from two samples would there-
fore not reflect real changes in the viral populations. In
order to further evaluate the biais of PCR and cloning in
the selection of variants present in a viral population and
to further demonstrate a turnover of individual genetic
variants in the SIVagm populations of AGMs and patas
monkeys studied, we realized HMA. HMA has already
been described as a first approach to rapidly determining
the pattern of viral variants in a swarm and to detecting
the presence of minor variants in a background of distinct
molecules (Delwart et al., 1993). Two sequential SIVagm
isolates from either AGM87 or PAT63 were compared to
each other and to their respective inoculum (Fig. 3). Five
FIG. 3. Comparison of the viral populations present in the inoculumindependent PCRs were realized on each inoculum and
of AGM87 and PAT63 and in two respective sequential SIVagm isolateseach sequential isolate. The quasispecies pattern was
from these monkeys by heteroduplex mobility assays. Single-strand
identical for each PCR product from a same sample (data DNA (S) and homoduplexes (H) are indicated by arrows; the bands
not shown), but different samples showed distinct hetero- in between correspond to heteroduplexes. Lane 7, molecular weight
marker. (A) AGMB87. Lanes 1, 2, and 3, PCR products of, respectively,duplex patterns (Fig. 3). For example, the inoculum used
inoculum, isolate B, and isolate C; lanes 4, 5, and 6, mixtures of PCRto infect the AGMB87 showed two slow migrating hetero-
products, respectively, of inoculum and isolate B, inoculum and isolateduplexes (Fig. 3A, lane 1), which were not observed in
C, isolate B and isolate C. (B) PAT63. Lanes 1, 2, and 3, PCR products
two sequential isolates of AGMB87 (Fig. 3A, lanes 2 and of, respectively, inoculum, isolate A, and isolate B; lanes 4, 5, and 6,
3). Two unique, very slowly migrating heteroduplexes mixtures of PCR products, respectively, of inoculum and isolate A,
inoculum and isolate B, isolate A and isolate B.were identified within the AGMB87 C isolate (Fig. 3A,
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TABLE 4
Ratios of Synonymous to Nonsynonymous Substitutions (Ks/Ka) in the V3 to V5 env Region during Nonpathogenic SIVagm Infectionsa
AGMB14 AGMB86 AGMB87 PAT40 PAT63 PAT87
A B C A B A B C A B A B A B
1.8 2.1 1.7 2.1 4.6 2.6 4.4 4.9 1.8 2.1 3.0 2.0 6.2 1.5
a The ratios were determined between SIVagm env sequences that were found to be related to each other in the minimal trees established for
each isolate. A, B, and C refer to the first, second, or third isolate.
heterogenous than the first one. These results confirm infection were Asian monkeys, in particular pigtailed ma-
that changes in the viral populations take place over time caques (Gravell et al., 1989; Hartung et al., 1990; Hirsch et
in one SIVagm-infected AGM and in one SIVagm-infected al., 1995). We succeeded in reproducibly and persistently
patas monkey. They support our estimates of the fixation infecting an African nonhuman primate species, the pa-
rate of nucleotide substitutions in SIVagm viral popula- tas monkey, with SIVagm.tan (Table 1). One SIVagm.tan
tions in vivo, which are similar to that previously estab- cross-species transmission through bites from an AGM
lished for clones of SIVagm.ver in vivo (Baier et al., 1991; to a patas monkey in captivity was also observed (unpub-
Fomsgaard et al., 1993). lished observation). Cross-species transmissions of
SIVagm probably also occur in natura, since SIVagm-
The fixation rate of nonsynonymous substitutions in related lentiviruses were recently identified in one wild-
the V3-V5 env region is low during nonpathogenic caught patas monkey (Bibollet-Ruche et al., 1996) and in
SIVagm infections naturally infected baboons (Jin et al., 1994b). It is, how-
ever, surprising that SIVagm infections were not identi-Changes in viral populations do not reflect accumula-
fied in many other wild-caught patas (Herve´ et al., 1992;tion of neutral mutations, but rather the response of a
Lowenstine et al., 1986), although patas monkeys sharesufficiently large and divergent population to a variety of
the same habitat as AGMs and interspecies contacts areselective pressures (Coffin, 1995). In order to determine
known to occur occasionally (Galat-Luong, 1991). Al-whether SIVagm is submitted to distinct selective pres-
though SIVagm can easily be experimentally transmittedsures in its natural host and in patas monkeys, we evalu-
to patas monkeys, it appears that cross-species trans-ated the ratios of the synonymous to nonsynonymous
mission events in natura are rare.substitution frequencies (Ks/Ka). The results are shown
in Table 4. The ratios ranged from 1.7 to 4.9 for AGMs Our experimental transmission study shows that
and from 1.5 to 6.2 for patas monkeys. The mean values SIVagm-infected patas monkeys do not develop any clini-
were, respectively, 3.04 and 2.77 in the experimentally cal signs of immunodeficiency, at least during a 312-year
infected AGM and patas monkeys. The Ks/Ka ratios are follow-up. Patas monkeys are large animals with long
therefore not significantly different for SIVagm env se- limbs and the capacity for running fast (van der Kuyl et al.,
quences in these two distinct monkey species. 1995). Because of its characteristics, the patas monkey is
If we assume that the synonymous substitutions are generally excluded from the Cercopithecus group and
not under a selective pressure, these values mean that classified into a separate genus (Erythrocebus). How-
only a portion of the emerging nonsynonymous mutations ever, they are one of the species most closely related
in env (20–57% in AGMs and 16–67% in patas) are fixed to AGMs (Cronin and Sarich, 1976). It has even been
in both species. These fixation rates of nonsynonymous suggested to rename them Cercopithecus patas. This
mutations are lower for SIVagm in the natural host and close relationship between patas and AGMs may explain
in patas monkeys than those during pathogenic HIV-1 why, like AGMs, the infected patas monkeys do not de-
and SIVmac infections (Balfe et al., 1990; Burns and Des- velop any disease.
rosiers, 1991; Chackerian et al., 1994; Johnson et al., Although the patas monkeys did not show clinical
1991; Kodama et al., 1993; Overbaugh et al., 1991; Pel- symptoms in response to a SIVagm infection, we were
letier et al., 1995). It is also interesting to notice that in interested to see whether the genetic evolution of
the experimentally infected AGMs, the Ks/Ka ratios seem SIVagm is nonetheless different in this foreign host spe-
to increase over time, but decrease in two of the three cies and in the natural host. The longitudinal evolution
experimentally infected patas monkeys (Table 4). of SIVagm variants present in PBMCs of three AGMs and
three patas monkeys was thus analyzed. Proviral DNA
DISCUSSION in PBMCs probably does not represent the predominant
viruses expressed at the time point of analysis (Sim-Up to now, the only foreign monkey species that were
shown to be highly susceptible to experimental SIVagm monds et al., 1991), but it should nonetheless be globally
AID VY 8090 / 6a1d$$$223 08-05-96 14:05:21 vira AP: Virology
99INTRAHOST GENETIC EVOLUTION OF SIVagm
representative of the genetic evolution of the viral popula- Synonymous to nonsynonymous mutation ratios (Ks/
Ka) are indicative of the selective pressures exerted intion in the host. It was reported indeed that the PBMC
proviral DNA reflects the viral RNA population, but with the host on the virus. Our data on the V3 to V5 env
sequences of SIVagm indicate similar Ks/Ka ratios ina delay (Lineberger et al., 1995; Simmonds et al., 1991;
Wei et al., 1995) and, as a consequence, phylogenetic AGMs (1.8 – 4.9) and patas monkeys (1.5 – 6.2) (Table 4).
The low frequencies of nonsynonymous mutations welineages can be established over longer time periods
with PBMC DNA than with virion RNA (Delwart et al., determined for SIVagm.tan in AGM and patas monkeys
contrast with those reported for another env region1995). The phylogenetic pattern of the SIVagm variants
that we identified in donor and recipient AGMs (Fig. 2) (V1/V2 region) in one AGM (vervet) infected with a
SIVagm.ver molecular clone (Baier et al., 1991). Thesuggests the transmission and persistence of multiple
SIVagm variants in the natural host. In contrast, only ge- authors reported a higher percentage of nonsynony-
mous mutations. Such a discrepancy might be ex-netically very closely related variants were detected in
patas monkeys. Our recent data on the comparative viral plained by distinct selective pressures acting on the
N- and C-terminal regions of the SU. Our Ks/Ka ratiosload in AGMs and patas monkeys indicate that the lower
genetic heterogeneity of SIVagm in patas does not corre- in the SU C-terminal half are significantly higher than
that described for pathogenic SIVmac, SIVsm, and HIV-late with a lower cellular viremia in these monkeys
(manuscript in preparation). These observations may be 1 in equivalent env regions (Balfe et al., 1990; Burns
and Desrosiers, 1991; Chackerian et al., 1994; Johnsonconsistent with a selection of a single or a few closely
related variants present in the inoculum during or soon et al., 1991; Kodama et al., 1993; Overbaugh et al., 1991;
Pelletier et al., 1995). Studies based on interhost vari-after transmission of SIVagm into patas monkeys, simi-
larly to what has been reported for HIV-1-infected adults ability already suggested a lower fixation rate of non-
synonymous mutations during nonpathogenic infec-and children (Wolinsky et al., 1992; Zhang et al., 1993;
Zhu et al., 1993). We cannot exclude that the 6-day PBMC tions (Johnson et al., 1990; Myers et al., 1994; Shpaer
and Mullins, 1993). Intrahost studies in HIV-1-infectedin vitro culture before analysis reduced the SIVagm ge-
netic complexity in a more important manner for patas adults showed Ks/Ka values ranging from 0.35 to 1.9
for the V3 and V4 – V5 regions (Balfe et al., 1990; Lukas-than for AGM PBMCs. But in either case, distinct selec-
tive pressures would act on SIVagm according to the hov et al., 1995; Wolinsky et al., 1992). Surprisingly, the
lowest Ks/Ka ratios were reported for slow progressorshost species environment.
The differences in the degree of SIVagm genetic het- (0.35) (Lukashov et al., 1995). Although from a clinical
point of view, the slow progressors resemble more theerogeneity according to the host species does not inter-
fere with the rates at which the viruses accumulate muta- asymptomatically infected African monkeys than the
rapid progressors do, the differences in the Ks/Ka ratiostions. They appear indeed similar for both species (0.4 –
7.2 1 1002 substitutions per site and per year). These indicate that the intrahost evolution in pathogenic and
nonpathogenic infections is not driven by the samemutation fixation rates are also similar to the ones re-
ported previously for pathogenic SIVmac or SIVsm clones forces. It was suggested that in HIV-infected slow pro-
gressors, the higher fixation rate of nonsynonymousin macaques and HIV-1 in humans (0–111 1002 substitu-
tions per site and per year) (Balfe et al., 1990; Burns and mutations is related to the persistent cytotoxic T-lym-
phocyte response that maintains strong positive selec-Desrosiers, 1991; Johnson et al., 1991; Pelletier et al.,
1995). If we assume that most mutations are introduced tive pressures for change (Lukashov et al., 1995). In
AGMs, the pressures for change appear less strong.by the reverse transcriptase during the replication cycle,
only a continuous replication of SIVagm, as reported for The intraspecies viral evolution in the long run may
have lead to the selection of SIVagm viruses that areHIV (Ho et al., 1995; Wain-Hobson, 1993; Wei et al., 1995),
could explain the mutation rates we observed in infected highly adapted to their environment (Shpaer and Mul-
lins, 1993). Under these circumstances, the selectiveAGMs and patas. According to recent data, SIVagm-in-
fected vervets (Hirsch et al., 1995) and tantalus monkeys pressures are more conservative since virus and host
are in an apparent optimum state of balance.(manuscript in preparation) present a low-level viremia
and only a very few virus-expressing cells in their lymph The results presented here gave an insight into the
genetic evolution of nonpathogenic SIVagm in vivo. Theynodes. A low viral burden is not inconsistent with a con-
tinuous viral multiplication of SIVagm in vivo, if de novo support that SIVagm is highly adapted to its natural host.
They also suggest that the differences between non-infection constantly occurs, but at a much lower level
than that in humans (Ho et al., 1995; Wei et al., 1995). It pathogenic SIVagm and pathogenic HIV/SIV infections
are not related to a lower ability of nonpathogenic viruseswas suggested that host factors like IL-16 contribute to
the low viral load in AGMs by suppressing viral replica- to replicate in vivo. Our study highlights the necessity of
further investigations on nonpathogenic lentivirus mod-tion (Baier et al., 1995). The mechanisms responsible for
the low viral burden in AGMs remain, however, far from els, in particular on the host factors that are involved in
the absence of progression to AIDS.being fully understood up to now.
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